Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer
Journal of Clinical Oncology · 10.11.2026 · 44 (32) · 3083-3087
DOI: 10.1200/jco-26-01914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.11.2026. Verfasst von Amandeep Aujla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hartford Healthcare Cancer Institute, Backus Hospital, Norwich, CT. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hartford Healthcare Cancer Institute, Backus Hospital, Norwich, CT.
- Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
ORCID-Profile: Amandeep Aujla, Jibran Ahmed
Zitieren
APA
Aujla, A., & Ahmed, J. (2026). Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer. Journal of Clinical Oncology, 44(32), 3083-3087. https://doi.org/10.1200/jco-26-01914
Vancouver
Aujla A, Ahmed J. Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer. Journal of Clinical Oncology. 2026;44(32):3083-3087. doi:10.1200/jco-26-01914
BibTeX
@article{Aujla2026,
author = {Aujla, Amandeep and Ahmed, Jibran},
title = {Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {32},
pages = {3083--3087},
doi = {10.1200/jco-26-01914}
}
EUVIMED